All In MedTech

FDA Clearance Tracker · P070004-S033

Sientra OPUS Silicone Gel Breast Implants

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 27, 2021 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 27, 2021

Approved

Time to decision

82 days

Received Aug 6, 2021. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P070004-S033
Device name
Sientra OPUS Silicone Gel Breast Implants
Applicant location
Franklin, WI
Received
Aug 6, 2021
Decided
Oct 27, 2021
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Labeling Change - Indications/instructions/shelf life/tradename
Original approval
P070004

Device type

Device class
Class III
Regulation
21 CFR 878.3540

Every decision under product code FTR

FDA's approval statement

As written in FDA's record.

Approval for changes to the patient and physician labeling including a boxed warning and a patient decision checklist.

Source documents

Other decisions for Tiger Aesthetics Medical, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

No other decisions since 2015 under this exact applicant name.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.